Company intelligence / Profile preview

GEM Global Yield Fund

Luxembourg, Luxembourg

Ownership: Private
Employees: ~50
Development stage: Other

Overview

GEM Global Yield Fund is an investment vehicle managed by Global Emerging Markets (GEM), focusing on providing tailored financing solutions such as share subscription facilities to growth-stage companies across various sectors, including but not limited to health and biotech; it is not itself a developer of health, biotech, or pharma products[1][2][4][6][10].

Industry: Investors

Partnerships

Kensana HealthTurn TherapeuticsStramsen BiotechRenexxion Ireland

Beyond the preview

Go deeper on GEM Global Yield Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GEM Global Yield Fund.

Explore the full profile